Tessera Therapeutics
Biotechnology ResearchMassachusetts, United States201-500 Employees
Our Gene Writing™ technology advances genetic medicine beyond its current limitations. Learn more at http://TesseraTherapeutics.com
Insights
Gene Writing Technology Tessera Therapeutics utilizes Gene Writing™ technology, offering a unique value proposition in genetic medicine that can attract interest from biotech companies seeking innovative solutions.
Financial Health With a revenue range of $10M - 50M and recent funding of $300M, Tessera Therapeutics demonstrates financial stability and growth potential, making them a promising partner for businesses in the biotech industry.
Strategic Location Being based in Somerville, MA, a hub for biotechnology research and innovation, positions Tessera Therapeutics strategically to collaborate with local companies looking for partnerships in cutting-edge genetic medicine.
Competitive Landscape Comparative analysis with similar companies like Beam Therapeutics, Editas Medicine, and Guardant Health reveals Tessera Therapeutics' competitive edge in terms of employee size and revenue, showcasing opportunities for differentiation in the market.
Tech Stack & Innovation By employing advanced technologies such as Craft CMS, Python, and Tailwind CSS in their operations, Tessera Therapeutics displays a commitment to innovation and efficiency, making them an attractive prospect for tech-savvy biotech partners.
Similar companies to Tessera Therapeutics
Fulgent Genetics
$50M$100MBeam Therapeutics
$100M$1BMyriad Genetics
$100M$1BSarepta Therapeutics
$100M$1BNatera
$100M$1BEditas Medicine
$50M$100MThermo Fisher Scientific
$1BCRISPR Therapeutics
$50M$100MAgilent Technologies
$1BGuardant Health
$100M$1BIllumina
$1B
Tessera Therapeutics Tech Stack
Tessera Therapeutics uses 8 technology products and services including Craft CMS, BugHerd, Polyfill, and more. Explore Tessera Therapeutics's tech stack below.
- Craft CMSContent Management System
- BugHerdIssue Trackers
- PolyfillJavascript Libraries
- Open GraphMiscellaneous
- PHPProgramming Languages
- SEOmaticSearch Engines
- Tailwind CSSUI Frameworks
- NginxWeb Servers
Media & News
Tessera Therapeutics's Email Address Formats
Tessera Therapeutics uses at least 1 format(s):
| Tessera Therapeutics Email Formats | Percentage |
| FLast@tesseratx.com | 73% |
| First.Last@tesseratx.com | 23% |
| First@tesseratx.com | 3% |
| Last@tesseratx.com | 1% |
Frequently Asked Questions
Where is Tessera Therapeutics's headquarters located?
Tessera Therapeutics's main headquarters is located at Somerville, MA 02143 US. The company has employees across 3 continents, including North AmericaEuropeAsia. What is Tessera Therapeutics's official website and social media links?
Tessera Therapeutics's official website is tesseratx.com and has social profiles on LinkedIn.How much revenue does Tessera Therapeutics generate?
As of November 2024, Tessera Therapeutics's annual revenue reached $35M. What is Tessera Therapeutics's SIC code NAICS code?
Tessera Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Tessera Therapeutics have currently?
As of November 2024, Tessera Therapeutics has approximately 336 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. S.Chief Operating Officer: H. P.Chief Scientific Officer: M. H.. Explore Tessera Therapeutics's employee directory with LeadIQ.What industry does Tessera Therapeutics belong to?
Tessera Therapeutics operates in the Biotechnology Research industry. What technology does Tessera Therapeutics use?
Tessera Therapeutics's tech stack includes Craft CMSBugHerdPolyfillOpen GraphPHPSEOmaticTailwind CSSNginx. What is Tessera Therapeutics's email format?
Tessera Therapeutics's email format typically follows the pattern of . Find more Tessera Therapeutics email formats with LeadIQ. How much funding has Tessera Therapeutics raised to date?
As of November 2024, Tessera Therapeutics has raised $300M in funding. The last funding round occurred on Apr 19, 2022 for $300M.
Company Overview
- Headquarters
- Somerville, MA 02143 US
- Website
- tesseratx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 201-500
Funding & Financials
- $300M
Tessera Therapeutics has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Apr 19, 2022 in the amount of $300M.
- $10M$50M
Tessera Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $300M
Tessera Therapeutics has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Apr 19, 2022 in the amount of $300M.
- $10M$50M
Tessera Therapeutics's revenue is in the range of $10M$50M
Company Leadership
M. S.Chief Executive Officer- H. P.Chief Operating Officer
M. H.Chief Scientific Officer
B. L.Chief Human Resources Officer- I. M.Chief Data Officer
Employee Directory
- J. R.Co-Founder
- M. S.Chief Executive Officer
- I. M.Chief Data Officer
- R. C.Co-Founder And Advisor
- D. N.Chief Data Officer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
